<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nogr</journal-id><journal-title-group><journal-title xml:lang="ru">Экспериментальная и клиническая гастроэнтерология</journal-title><trans-title-group xml:lang="en"><trans-title>Experimental and Clinical Gastroenterology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1682-8658</issn><publisher><publisher-name>«Global Media Technologies»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.31146/1682-8658-ecg-205-9-183-189</article-id><article-id custom-type="elpub" pub-id-type="custom">nogr-2055</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОР</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEW</subject></subj-group></article-categories><title-group><article-title>Скрининг колоректального рака: как решается проблема в России и мире</article-title><trans-title-group xml:lang="en"><trans-title>Сolorectal cancer screening: how the problem is solved in Russia and the world</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4878-0838</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лялюкова</surname><given-names>Елена Александровна</given-names></name><name name-style="western" xml:lang="en"><surname>Lyalyukova</surname><given-names>E. A.</given-names></name></name-alternatives><email xlink:type="simple">lyalykova@rambler.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Аманатидис</surname><given-names>Людмила Артуровна</given-names></name><name name-style="western" xml:lang="en"><surname>Amanatidis</surname><given-names>L. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Коновалова</surname><given-names>Галина Михайловна</given-names></name><name name-style="western" xml:lang="en"><surname>Konovalova</surname><given-names>G. M.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Овсянникова</surname><given-names>София Юрьевна</given-names></name><name name-style="western" xml:lang="en"><surname>Ovsyannikova</surname><given-names>S. Yu.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО «Омский государственный медицинский университет» Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Omsk State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБОУ ВО «Майкопский государственный технологический университет»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Maykop State Technological University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>07</day><month>10</month><year>2022</year></pub-date><volume>0</volume><issue>9</issue><fpage>183</fpage><lpage>189</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Лялюкова Е.А., Аманатидис Л.А., Коновалова Г.М., Овсянникова С.Ю., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Лялюкова Е.А., Аманатидис Л.А., Коновалова Г.М., Овсянникова С.Ю.</copyright-holder><copyright-holder xml:lang="en">Lyalyukova E.A., Amanatidis L.A., Konovalova G.M., Ovsyannikova S.Y.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.nogr.org/jour/article/view/2055">https://www.nogr.org/jour/article/view/2055</self-uri><abstract><p>Колоректальный рак - актуальная проблема здравоохранения России и других стан. Цель работы- представить современные данные по программам скрининга КРР. Обзор современных рекомендаций показал эффективность скрининговых программ с использованием тестов на скрытую кровь и фиброколоноскопии в снижении заболеваемости и смертности от колоректального рака. Реализация скрининговых программ в России представлена как часть развития профилактической медицины в целом.</p></abstract><trans-abstract xml:lang="en"><p>Colorectal cancer is an urgent health problem in Russia and other countries. The aim is to present up-to-date data on CRC screening programs. A review of current recommendations has shown the effectiveness of screening programs using occult blood tests and fibrocolonoscopy in reducing morbidity and mortality from colorectal cancer. The implementation of screening programs in Russia is presented as part of the development of preventive medicine in general.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>колоректальный рак</kwd><kwd>скрининг</kwd><kwd>фиброколоноскопия</kwd></kwd-group><kwd-group xml:lang="en"><kwd>colorectal cancer</kwd><kwd>screening</kwd><kwd>fibrocolonoscopy</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Ansa B.E., Coughlin S. S., Alema-Mensah E., et al. Evaluation of Colorectal Cancer Incidence Trends in the United States (2000-2014). J Clin Med.2018;7(22):310-321. doi:10.3390/jcm7020022</mixed-citation><mixed-citation xml:lang="en">Ansa B.E., Coughlin S. S., Alema-Mensah E., et al. Evaluation of Colorectal Cancer Incidence Trends in the United States (2000-2014). J Clin Med.2018;7(22):310-321. doi:10.3390/jcm7020022</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Sung H., Ferlay J., Siegel R. L., et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A CANCER Journal for Clinicians. 2021;71(3):209-249. doi: 10.3322/caac.21660</mixed-citation><mixed-citation xml:lang="en">Sung H., Ferlay J., Siegel R. L., et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A CANCER Journal for Clinicians. 2021;71(3):209-249. doi: 10.3322/caac.21660</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Oskombaev M. Sh., Dzhekshenov M. D., Satybaldiev O. A., et al. Epidemiology of colorectal cancer. Scientific review. Medical sciences.2021;1(7):37-42. (In Russ.) doi:10.17513/srms.1169 @@Осомбаев М. Ш., Джекшенов М. Д., Сатыбалдиев О. А. и соавт. Эпидемиология колоректального рака. Научное обозрение. Медицинские науки. 2021;1(7):37-42. doi:10.17513/srms.1169</mixed-citation><mixed-citation xml:lang="en">Oskombaev M. Sh., Dzhekshenov M. D., Satybaldiev O. A., et al. Epidemiology of colorectal cancer. Scientific review. Medical sciences.2021;1(7):37-42. (In Russ.) doi:10.17513/srms.1169 @@Осомбаев М. Ш., Джекшенов М. Д., Сатыбалдиев О. А. и соавт. Эпидемиология колоректального рака. Научное обозрение. Медицинские науки. 2021;1(7):37-42. doi:10.17513/srms.1169</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Kaprin A.D., Starinsky V. V., Shakhzadova A. O., et al. Malignant neoplasms in Russia in 2019 (morbidity and mortality). Moscow. P. A. Herzen Moscow State Medical Research Institute - Branch of the Federal State Budgetary Institution “NMIC of Radiology” of the Ministry of Health of Russia. 2020;(1):72-79. (In Russ.) @@Каприн А. Д., Старинский В. В., Шахзадова А. О. и соавт. Злокачественные новообразования в России в 2019 году (заболеваемость и смертность). М.: МНИОИ им. П. А. Герцена - филиал ФГБУ «НМИЦ радиологии» Минздрава России. 2020;1:72-79.</mixed-citation><mixed-citation xml:lang="en">Kaprin A.D., Starinsky V. V., Shakhzadova A. O., et al. Malignant neoplasms in Russia in 2019 (morbidity and mortality). Moscow. P. A. Herzen Moscow State Medical Research Institute - Branch of the Federal State Budgetary Institution “NMIC of Radiology” of the Ministry of Health of Russia. 2020;(1):72-79. (In Russ.) @@Каприн А. Д., Старинский В. В., Шахзадова А. О. и соавт. Злокачественные новообразования в России в 2019 году (заболеваемость и смертность). М.: МНИОИ им. П. А. Герцена - филиал ФГБУ «НМИЦ радиологии» Минздрава России. 2020;1:72-79.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Smith R.A., Andrews K. S., Brooks D., et al. Cancer Screening in the United States, 2019: A Review of Current American Cancer Society Guidelines and Current Issues in Cancer Screening. CA: A CANCER Journal for Clinicians. 2019;69(3):184-210. doi:10.3322/caac.21557</mixed-citation><mixed-citation xml:lang="en">Smith R.A., Andrews K. S., Brooks D., et al. Cancer Screening in the United States, 2019: A Review of Current American Cancer Society Guidelines and Current Issues in Cancer Screening. CA: A CANCER Journal for Clinicians. 2019;69(3):184-210. doi:10.3322/caac.21557</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Cancer Screening in the European Union (2017) Report on the implementation of the Council Recommendation on cancer screening. 2017, International Agency for Research on Cancer. Available at: https://ec.europa.eu/health/sites/health/files/major_chronic_diseases/docs/2017_cancerscreening_2ndreportimplementation_en.pdf (accessed: 05.05.2021.)</mixed-citation><mixed-citation xml:lang="en">Cancer Screening in the European Union (2017) Report on the implementation of the Council Recommendation on cancer screening. 2017, International Agency for Research on Cancer. Available at: https://ec.europa.eu/health/sites/health/files/major_chronic_diseases/docs/2017_cancerscreening_2ndreportimplementation_en.pdf (accessed: 05.05.2021.)</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Siegel R. L., Fedewa S. A., Anderson W. F., et al. Colorectal cancer incidence patterns in the United States. 1974-2013. J Natl Cancer Inst. 2017;109(8):1-6. doi:10.1093/jnci/djw322</mixed-citation><mixed-citation xml:lang="en">Siegel R. L., Fedewa S. A., Anderson W. F., et al. Colorectal cancer incidence patterns in the United States. 1974-2013. J Natl Cancer Inst. 2017;109(8):1-6. doi:10.1093/jnci/djw322</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Chen F. W., Sundaram V, Chew T. A., et al. Advanced-stage colorectal cancer in persons younger than 50 years not associated with longer duration of symptoms or time to diagnosis. Clin Gastroenterol Hepatol.2017;15:728-737, e723. doi:10.1016/j.cgh.2016.10.038</mixed-citation><mixed-citation xml:lang="en">Chen F. W., Sundaram V, Chew T. A., et al. Advanced-stage colorectal cancer in persons younger than 50 years not associated with longer duration of symptoms or time to diagnosis. Clin Gastroenterol Hepatol.2017;15:728-737, e723. doi:10.1016/j.cgh.2016.10.038</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Scott R. B., Rangel L. E., Osler T. M., et al. Rectal cancer in patients under the age of 50 years: the delayed diagnosis. Am J Surg. 2016;211(6):1014-1018. doi:10.1016/j.amjsurg.2015.08.031</mixed-citation><mixed-citation xml:lang="en">Scott R. B., Rangel L. E., Osler T. M., et al. Rectal cancer in patients under the age of 50 years: the delayed diagnosis. Am J Surg. 2016;211(6):1014-1018. doi:10.1016/j.amjsurg.2015.08.031</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Siegel R.L., Miller K. D., Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67(1):7-30. doi: 10.3322/caac.21387</mixed-citation><mixed-citation xml:lang="en">Siegel R.L., Miller K. D., Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67(1):7-30. doi: 10.3322/caac.21387</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Giardiello F.M., Allen J. I., Axilbund J. E., et al. Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol. 2014;147(2):502-526. doi:10.1053/j.gastro.2014.04.001</mixed-citation><mixed-citation xml:lang="en">Giardiello F.M., Allen J. I., Axilbund J. E., et al. Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol. 2014;147(2):502-526. doi:10.1053/j.gastro.2014.04.001</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Wood M.E., Kadlubek P., Pham T. H., et al. Quality of cancer family history and referral for genetic counseling and testing among oncology practices: a pilot test of quality measures as part of the American Society of Clinical Oncology Quality Oncology Practice Initiative. J Clin Oncol. 2014;32(8):824-829. doi: 10.1200/JCO.2013.51.4661</mixed-citation><mixed-citation xml:lang="en">Wood M.E., Kadlubek P., Pham T. H., et al. Quality of cancer family history and referral for genetic counseling and testing among oncology practices: a pilot test of quality measures as part of the American Society of Clinical Oncology Quality Oncology Practice Initiative. J Clin Oncol. 2014;32(8):824-829. doi: 10.1200/JCO.2013.51.4661</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Lowery J.T., Ahnen D. J., Schroy P. C. 3rd, et al. Understanding the contribution of family history to colorectal cancer risk and its clinical implications: a state-of-the science review. Cancer. 2016;122(17):2633-2645. doi: 10.1002/cncr.30080</mixed-citation><mixed-citation xml:lang="en">Lowery J.T., Ahnen D. J., Schroy P. C. 3rd, et al. Understanding the contribution of family history to colorectal cancer risk and its clinical implications: a state-of-the science review. Cancer. 2016;122(17):2633-2645. doi: 10.1002/cncr.30080</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Chissov V.I., Sergeyeva N. S., Zenkina Ye.V., et al. Evolution of copro-tests in active detection of colorectal cancer. Coloproctology News. 2012;6 (In Russ.) @@Чиссов В. И., Сергеева Н. С., Зенкина Е. В., и соавт. Эволюция копро-тестов в активном выявлении колоректального рака. Новости колопроктологии. 2012;6.</mixed-citation><mixed-citation xml:lang="en">Chissov V.I., Sergeyeva N. S., Zenkina Ye.V., et al. Evolution of copro-tests in active detection of colorectal cancer. Coloproctology News. 2012;6 (In Russ.) @@Чиссов В. И., Сергеева Н. С., Зенкина Е. В., и соавт. Эволюция копро-тестов в активном выявлении колоректального рака. Новости колопроктологии. 2012;6.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Order of the Ministry of Health of the Russian Federation No. 404n dated April 27, 2021 “On approval of the procedure for preventive medical examination and medical examination of certain groups of the adult population”. (In Russ.) @@Приказ Министерства здравоохранения РФ № 404н от 27 апреля 2021 г «Об утверждении порядка проведения профилактического медицинского осмотра и диспансеризации определенных групп взрослого населения»</mixed-citation><mixed-citation xml:lang="en">Order of the Ministry of Health of the Russian Federation No. 404n dated April 27, 2021 “On approval of the procedure for preventive medical examination and medical examination of certain groups of the adult population”. (In Russ.) @@Приказ Министерства здравоохранения РФ № 404н от 27 апреля 2021 г «Об утверждении порядка проведения профилактического медицинского осмотра и диспансеризации определенных групп взрослого населения»</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Lee Y.C., Li-Sheng Chen S., Ming-Fang Yen A., et al. Association between colorectal cancer mortality and gradient fecal hemoglobin concentration in colonoscopy noncompliers [serial online]. J Natl Cancer Inst. 2017;109(5). pii: 2740720. doi:10.1093/jnci/djw269</mixed-citation><mixed-citation xml:lang="en">Lee Y.C., Li-Sheng Chen S., Ming-Fang Yen A., et al. Association between colorectal cancer mortality and gradient fecal hemoglobin concentration in colonoscopy noncompliers [serial online]. J Natl Cancer Inst. 2017;109(5). pii: 2740720. doi:10.1093/jnci/djw269</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Corley D.A., Jensen C. D., Quinn V. P., et al. Association between time to colonoscopy after a positive fecal test result and risk of colorectal cancer and cancer stage at diagnosis. JAMA. 2017;317(16):1631-1641. doi: 10.1001/jama.2017.3634</mixed-citation><mixed-citation xml:lang="en">Corley D.A., Jensen C. D., Quinn V. P., et al. Association between time to colonoscopy after a positive fecal test result and risk of colorectal cancer and cancer stage at diagnosis. JAMA. 2017;317(16):1631-1641. doi: 10.1001/jama.2017.3634</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Selby K., Baumgartner C., Levin T. R., et al.Interventions to improve follow-up of positive results on fecal blood tests: a systematic review. Ann Intern Med. 2017;167(8): 565-575. doi: 10.7326/M17-1361</mixed-citation><mixed-citation xml:lang="en">Selby K., Baumgartner C., Levin T. R., et al.Interventions to improve follow-up of positive results on fecal blood tests: a systematic review. Ann Intern Med. 2017;167(8): 565-575. doi: 10.7326/M17-1361</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Passport of the national project “Healthcare”. approved by the Presidium of the Council under the President of the Russian Federation for Strategic Development and National Projects, Protocol No. 16 of December 24, 2018. (In Russ.) @@Паспорт национального проекта «Здравоохранение» (утв. Президиумом Совета при Президенте Российской Федерации по стратегическому развитию и национальным проектам, протокол от 24 декабря 2018 г. n 16)</mixed-citation><mixed-citation xml:lang="en">Passport of the national project “Healthcare”. approved by the Presidium of the Council under the President of the Russian Federation for Strategic Development and National Projects, Protocol No. 16 of December 24, 2018. (In Russ.) @@Паспорт национального проекта «Здравоохранение» (утв. Президиумом Совета при Президенте Российской Федерации по стратегическому развитию и национальным проектам, протокол от 24 декабря 2018 г. n 16)</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">FDA Authorizes Marketing of First Device that Uses Artificial Intelligence to Help Detect Potential Signs of Colon Cancer. Medical device aids clinicians in detecting potential irregularities during colon cancer screening and surveillance. Available at: URL: https://www.fda.gov/news-events/press-announcements/fda-authorizes-marketing-first-device-uses-artificial-intelligence-help-detect-potential-signs-colon. Accessed: 05.05.2021.</mixed-citation><mixed-citation xml:lang="en">FDA Authorizes Marketing of First Device that Uses Artificial Intelligence to Help Detect Potential Signs of Colon Cancer. Medical device aids clinicians in detecting potential irregularities during colon cancer screening and surveillance. Available at: URL: https://www.fda.gov/news-events/press-announcements/fda-authorizes-marketing-first-device-uses-artificial-intelligence-help-detect-potential-signs-colon. Accessed: 05.05.2021.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Yuichi Mori, Shin-ei Kudo, Masashi Misawa, et al. Artificial intelligence-assisted colonic endocytoscopy for cancer recognition: a multicenter study. Endoscopy International Open.202; 9(7): E1004-E1011. doi:10.1055/a-1475-3624</mixed-citation><mixed-citation xml:lang="en">Yuichi Mori, Shin-ei Kudo, Masashi Misawa, et al. Artificial intelligence-assisted colonic endocytoscopy for cancer recognition: a multicenter study. Endoscopy International Open.202; 9(7): E1004-E1011. doi:10.1055/a-1475-3624</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
